ACLY and myeloid sarcoma: These results indicate that, although in vitro inflammatory responses were increased in LysM-Cre-mediated Acly-deficient cells, myeloid Acly deficiency did not alter acute and chronic inflammatory disease outcomes in vivo in mouse models of obesity, peritonitis, and MS.